Quantification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and simultaneous ultraviolet-visible/radioactive detection
- 1 May 1992
- journal article
- Published by Elsevier in Analytical Biochemistry
- Vol. 203 (1), 116-120
- https://doi.org/10.1016/0003-2697(92)90050-h
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Suppression of deferoxamine mesylate treatment — induced side effects by coadministration of isoniazid in a patient with Alzheimer's disease subject to aluminum removal by ionspecific chelationClinical Pharmacology & Therapeutics, 1990
- Separation and identification of desferrioxamine and its iron chelating metabolites by high-performance liquid chromatography and fast atom bombardment mass spectrometry: Choice of complexing agent and application to biological fluidsAnalytical Biochemistry, 1990
- Ferrioxamine and its hexadentate iron-chelating metabolites in human post-desferal urine studied by high-performance liquid chromatography and fast atom bombardment mass spectrometryAnalytical Biochemistry, 1990
- EFFECT OF DESFERRIOXAMINE ON REMOVAL OF ALUMINIUM AND IRON BY COATED CHARCOAL HAEMOPERFUSION AND HAEMODIALYSISThe Lancet, 1983
- Coordination chemistry of microbial iron transport compounds. 21. Kinetics and mechanism of iron exchange in hydroxamate siderophore complexesJournal of the American Chemical Society, 1981
- SUCCESSFUL REMOVAL OF ALUMINIUM FROM PATIENT WITH DIALYSIS ENCEPHALOPATHYThe Lancet, 1980
- The metabolism of desferrioxamine B and ferrioxamine BBiochemical Pharmacology, 1967
- The Biochemistry of Desferrioxamine and its Relation to Iron MetabolismAnnals of the New York Academy of Sciences, 1964